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Vδ2+ T cell response to malaria 
correlates with protection from 
infection but is attenuated with 
repeated exposure
Prasanna Jagannathan  1,2, Fredrick Lutwama3,4, Michelle J. Boyle2,5, Felistas Nankya6, Lila 
A. Farrington2, Tara I. McIntyre2, Katherine Bowen2, Kate Naluwu6, Mayimuna Nalubega6, 
Kenneth Musinguzi6, Esther Sikyomu6, Rachel Budker2, Agaba Katureebe6, John Rek6, Bryan 
Greenhouse2, Grant Dorsey2, Moses R. Kamya4 & Margaret E. Feeney2,7
Vδ2+ γδ T cells are semi-innate T cells that expand markedly following P. falciparum (Pf) infection in 
naïve adults, but are lost and become dysfunctional among children repeatedly exposed to malaria. 
The role of these cells in mediating clinical immunity (i.e. protection against symptoms) to malaria 
remains unclear. We measured Vδ2+ T cell absolute counts at acute and convalescent malaria timepoints 
(n = 43), and Vδ2+ counts, cellular phenotype, and cytokine production following in vitro stimulation at 
asymptomatic visits (n = 377), among children aged 6 months to 10 years living in Uganda. Increasing 
age was associated with diminished in vivo expansion following malaria, and lower Vδ2 absolute 
counts overall, among children living in a high transmission setting. Microscopic parasitemia and 
expression of the immunoregulatory markers Tim-3 and CD57 were associated with diminished Vδ2+ 
T cell pro-inflammatory cytokine production. Higher Vδ2 pro-inflammatory cytokine production was 
associated with protection from subsequent Pf infection, but also with an increased odds of symptoms 
once infected. Vδ2+ T cells may play a role in preventing malaria infection in children living in endemic 
settings; progressive loss and dysfunction of these cells may represent a disease tolerance mechanism 
that contributes to the development of clinical immunity to malaria.
Despite declines in malaria morbidity in parts of sub-Saharan Africa1, malaria causes hundreds of thousands of 
deaths annually, predominantly among young children1, 2. Children residing in endemic areas eventually acquire 
‘clinical’ immunity to malaria (i.e. they are protected against symptoms)3–5, but they commonly harbor parasites 
as asymptomatic and transmitting carriers6, 7. Although individuals generally do not appear to develop sterilizing 
immunity that prevents any infection, blood-stage parasite density declines with age and repeated exposure8, 
suggesting the development of immune responses that are able to limit blood stage replication. Importantly, 
pro-inflammatory responses that limit parasitemia may also lead to clinical symptoms; thus, ‘clinical’ immunity 
could depend upon the ability to down-modulate such responses, as suggested by recent data from our group and 
others9–11.
The Vγ9 Vδ2 subset of γδ T cells, which constitute 0.5 to 5% of peripheral T cells in humans, have been shown 
to robustly proliferate and produce pro-inflammatory cytokines in response to Pf antigen stimulation and to 
markedly expand following malaria infection in naïve hosts12–17. These cells (hereafter termed Vδ2 T cells) rapidly 
react to phosphoantigens produced by the plasmodial apicoplast, and have been shown to inhibit parasite growth 
in vitro via the release of cytotoxic granules containing granulysin18, 19. Given these attributes, Vδ2 T cells may 
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function as ready-made effector cells, and may be most important early in response to malaria infection, poten-
tially before the adaptive immune response to Pf has developed. Supporting this hypothesis, cytokine production 
from these cells has been associated with protection from high density P falciparum infection20, and higher base-
line percentages of these cells have recently been associated with protection from subsequent Pf infection among 
individuals receiving an experimental attenuated sporozoite vaccine21.
While Vδ2 T cells may play role in limiting parasite replication, their production of pro-inflammatory 
cytokine has been implicated in the pathogenesis of severe symptoms from malaria22. Thus, curtailing excessive 
Vδ2 T cell activation may be required for the development of clinical immunity to malaria. We have previously 
shown that repeated malaria was associated with a loss of Vδ2+ T cells in peripheral blood, decreased prolifer-
ation and cytokine production of these cells in response to malaria antigen stimulation, and upregulation of 
numerous genes associated with dampening of the immune response9, 23. Furthermore, loss and dysfunction of 
Vδ2+ T cells was associated with a lower likelihood of symptoms upon subsequent infection9. Notably, we did not 
find a significant association between Vδ2+ T cell parameters and protection from subsequent infection, although 
our prior studies were limited to small cohorts of children <5 years of age and were unable to fully account for 
heterogeneous exposure to mosquitoes.
In the present study, we extend our prior observations regarding the potential role of Vδ2+ T cells in medi-
ating clinical immunity to malaria, leveraging large and comprehensively characterized cohorts of children age 
6 months to 10 years from two regions of Eastern Uganda with differing transmission intensities [17]. We first 
evaluated Vδ2+ T cell absolute counts following symptomatic malaria episodes, hypothesizing that older chil-
dren – who have sustained more cumulative malaria exposure in a high transmission setting – would exhibit 
diminished in vivo Vδ2+ T cell proliferation. We then evaluated Vδ2+ T cell absolute counts, cellular phenotype 
and Pf stimulation-induced IFNγ and TNFα-production from asymptomatic children living in both high and 
low transmission settings, assessing relationships between these parameters with age, parasitemia, and malaria 
infection. Finally, we analyzed the relationship between Vδ2+ T cell parameters and prospective protection from 
both Pf infection and the likelihood of symptoms once infected. We adjusted our analyses for heterogeneity in 
exposure to mosquitos using household-level mosquito capture data [18,19]. We hypothesized that higher Vδ2+ 
T cell numbers and cytokine production would be associated with protection from infection, but that greater 
cytokine production from these cells would also be associated with symptoms among children who are infected.
Results
Symptomatic malaria is followed by in vivo expansion of Vδ2+ T cells in young but not in older 
children. It has previously been shown that both the absolute count and percentage of Vδ2+ T cells expand 
following a symptomatic malaria infection in naïve and malaria-susceptible adults15, 24. Thus it is somewhat par-
adoxical that we recently found Vδ2+ T cell frequencies to be markedly lower among two cohorts of Ugandan 
children following chronic and repeated malaria exposure9, 23. To address these seemingly contradictory obser-
vations, we measured absolute Vδ2+Vγ9+ CD3+ cell counts at the time of an acute malaria episode and 3, 6 and 
9 weeks post-infection among children aged 6 months to 10 years living in a highly endemic region of Uganda. 
In this setting, parasite prevalence (including both microscopic and sub-microscopic parasitemia) is very high, 
but the probability of symptoms if blood smear positive decreases dramatically with increasing age (Fig. 1a), 
consistent with the development of clinical immunity to malaria. Overall, we observed significant expansion 
of Vδ2+Vγ9+ T cell counts three weeks after an acute malaria episode (P = 0.001), with stable counts thereafter, 
although there was significant heterogeneity among individuals (Fig. 1b.) When stratified by age (<4 yrs, 4–7 yrs, 
and >7yrs), children aged 0− < 4 years had significantly greater Vδ2+ T cell expansion following acute malaria 
than children in older age strata (P < 0.001, Fig. 1c). Indeed, children aged >7 years had no significant expansion 
of Vδ2+ T cells, suggesting that expansion may be blunted following chronic repeated exposure. In contrast, total 
lymphocyte counts increased following acute malaria but this expansion was not influenced by age (P = 0.24). 
Figure 1. Age associated differences in probability of symptoms if infected and malaria-associated in vivo 
Vδ2+ T cell expansion among children in high transmission setting. (A) Increasing parasite prevalence, but 
lower probability of symptoms given patent infection with increasing age among children in Nagongera, 
Uganda. Point estimates and 95% confidence intervals derived using multilevel mixed effects logistic regression 
modeling. (B) Absolute Vδ2 T cell counts at time of malaria and 3, 6, and 9 weeks post-malaria (n = 43, 
Wilcoxon matched pairs signed-rank). (C) Absolute Vδ2 T cell counts during and after acute malaria episode, 
stratified by age (0- < 4 yrs, n = 13; 4- < 7 yrs, n = 16; 7–11 yrs, n = 14). Point estimates derived from repeated 
measures analysis using generalized estimating equations, controlling for Day 0 parasite density.
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Together, these data indicate that there are significant age-associated differences in expansion of Vδ2+ T cells 
following acute malaria in endemic settings, with younger children having significantly greater expansion than 
older children.
Increasing age is associated with lower absolute counts of Vδ2+ T cells in high, but not low, 
transmission settings. We have previously shown that repeated malaria leads to decreased percentages of 
circulating Vδ2+ T cells among children ≤4 years of age9, 23, but it is not clear whether this is due to an absolute vs. 
relative loss, as total lymphocyte counts decline gradually during childhood25. We assessed the absolute count of 
Vδ2+ T cells/μl among children aged 1–11 years of age living in high prevalence Nagongera and compared these 
with age-matched children living in the lower malaria transmission setting of Walukuba, Jinja. Children living in 
Nagongera had significantly fewer Vδ2+ T cells/μl (Fig. 2a), as well as a lower percentage of Vδ2+ T cells among 
total CD3+ cells (Supplementary Fig. 2a) than those living in Walukuba. In contrast, absolute total T cell counts 
(CD3+ lymphocytes) were similar in the two settings (Supplementary Fig. 1b), suggesting that malaria exposure 
leads to a selective loss of Vδ2+ T cells.
Some studies performed in non-malaria endemic settings have observed an age-associated increase in Vδ2+ 
T cells during childhood26, 27. We observed a sharp decline in Vδ2+ T cells between 0 to 4 years of age, plateauing 
between 4 and 11 years of age, among children living in Nagongera (Fig. 2b, Supplemental Fig. 2b), and no signif-
icant age-associated change in absolute Vδ2+ T cell counts among children in Walukuba, the lower transmission 
setting (Rs = −0.21, P = 0.24). Furthermore, we observed a subtle, but statistically significant, inverse association 
between age and Vδ2+ T cell production of the inflammatory cytokines IFNγ and TNF following in vitro stim-
ulation with P. falciparum–infected RBCs among children living in Nagongera (Rs = −0.15, P = 0.02), but not 
in the lower transmission setting (Rs = 0.09, P = 0.65). These data suggest that increasing age – a surrogate for 
cumulative exposure to malaria in high transmission settings - is associated with loss, in both percentage and 
absolute count, and dysfunction of circulating Vδ2+ T cells among children living in a high transmission setting.
Microscopic, but not submicroscopic, parasitemia is associated with lower Vδ2+ T cell counts 
and cytokine production following in vitro stimulation. We have previously reported no signifi-
cant relationship between concurrent parasitemia with either Vδ2+ T cell percentages or cytokine production 
from these cells following in vitro stimulation with P. falciparum–infected RBCs9. However, our earlier cohort 
had relatively few patients with microscopic parasitemia and a lack of data on sub-microscopic infection. In the 
present study, we found that children with microscopic parasitemia had significantly fewer circulating Vδ2+ T 
cells/μl than uninfected children or those with submicroscopic infection at the time of assay (Fig. 3a). We did 
not, however, observe a difference in Vδ2+ T cell counts between uninfected children and those with submicro-
scopic infection. We further examined the relationship between absolute Vδ2+ T cell counts and parasite densities 
among asymptomatic and symptomatic children with parasitemia. We found a significant inverse correlation 
between Vδ2+ T cell counts and parasite densities (Rs = −0.37, P = 0.001, Fig. 3b).
Similar results were obtained when evaluating the overall percentage of Vδ2+ T cells, and the percentage of 
Vδ2+ T cells that produced inflammatory cytokines (IFNg, TNF) following in vitro malaria antigen stimulation. 
Asymptomatic children with microscopic parasitemia had significantly lower overall Vδ2+ T cells percentages 
(Fig. 3c), and lower percentages of pro-inflammatory cytokine- producing Vδ2+ T cells (Fig. 3d), than uninfected 
children at the time of assay, but percentages were similar between uninfected children and those with submi-
croscopic infection. We also observed a significant inverse correlation between percentages of pro-inflammatory 
cytokine- producing Vδ2+ T cells and parasite densities among parasitemic children (Rs −0.24, P = 0.01). 
Figure 2. Vδ2+ T cell counts decline with increasing age among children living in high transmission setting. 
(A) Absolute CD3+Vδ2+ cells/μl among asymptomatic children aged 6 months to 11 years in high (Nagongera) 
vs low (Walukuba) transmission setting at the time of routine assesments, Wilcoxon Rank Sum. (B) Absolute 
CD3+ Vδ2+ cells/μl by age in Nagongera. Rs: Spearman Rho. Solid line represents best fit regression line and 
dashed line represents 95% CI.
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Together, these data reveal that concurrent microscopic parasitemia, and higher parasite densities, are associated 
with both lower counts and diminished pro-inflammatory cytokine production of Vδ2+ T cells.
Vδ2+ T cells from children living in high transmission settings upregulate markers of exhaus-
tion and replicative senescence which correlate with loss of effector functions. We have pre-
viously shown that repeated malaria exposure is associated with increased Vδ2 expression of several genes 
associated with immunomodulation9. These include the gene encoding CD57, a protein which has been asso-
ciated with replicative senescence of CD8+ T cells in the setting of chronic antigen exposure28; and HAVCR2, 
which encodes the receptor Tim-3, a cell surface molecule that has been implicated in tolerance and exhaustion 
of Th129, 30 and innate cells31. We assessed cell surface expression of CD57 and Tim-3 on Vδ2+ T cells and found 
expression of both markers to be significantly higher among children living in Nagongera in comparison to 
children living in Walukuba (Fig. 4a,b). Importantly, expression of both markers was associated with dimin-
ished Vδ2+ T cell cytokine production following stimulation (Fig. 4c,d). We also recently reported that CD16 
expression identifies antigen-unresponsive Vδ2 T cells23. Consistent with these observations, we observed 
an inverse association between CD16 expression and Vδ2 production of IFNγ and TNFα (Rho = −0.62, 
P < 0.001).
CD57 expression on Vδ2+ T cells increased with age among children living in Nagongera (Rs = 0.24, P = 0.03, 
Fig. 4e), but not in children living in the low-endemicity setting of Walukuba (Rs 0.12, P = 0.38). In contrast, 
Tim-3 expression was not associated with age (Rs 0.11, P = 0.31), but was significantly higher among children 
with asymptomatic parasitemia (both submicroscopic and microscopic, P = 0.01, Fig. 4f) These data are consist-
ent with the hypothesis that recurrent malaria leads to upregulation of multiple immunoregulatory pathways that 
dampen the immune response to malaria.
Higher Vδ2+ T cell counts and cytokine production are associated with protection from P. 
falciparum infection, but also with a greater odds of symptoms if infected. Finally, to evalu-
ate relationships between Vδ2+ T cell parameters and clinical immunity to malaria, we independently assessed 
Figure 3. Concurrent microscopic parasitemia associated with diminished Vδ2+ T cell counts and 
cytokine production following in vitro stimulation. (A) Absolute CD3+ Vδ2+ cells/μl among uninfected, 
submicroscopically infected, microscopically infected/asymptomatic, and microscopically infected/
symptomatic children living in high transmission setting. (B) Association between absolute CD3+ Vδ2+ cells/
μl and parasite densities among infected children (submicroscopically infected children have parasite density 
estimated at 10 parasites/μl). Shown is 95% confidence interval of best fit regression line. (C) Percentage of Vδ2+ 
cells among total CD3+ and (D) Percentage of Vδ2+ T cells producing cytokines following in vitro stimulation 
with P. Falciparum infected red blood cells among uninfected, submicroscopically infected, and microscopically 
infected/asymptomatic children living in high transmission setting. Rs: Spearman correlation. Between group 
comparisons made with Wilcoxon ranksum test. Median indicated by black bar.
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associations with both the odds of subsequent infection and, secondarily, the odds of symptoms if infected. For 
these analyses, we measured associations with the infection status at the time of subsequent routine quarterly 
surveillance in the year following the assessment among children living in the high transmission setting of 
Nagongera.
Figure 4. Vδ2+ T cell expression of markers of exhaustion and replicative senescence correlate with loss of 
effector functions. Vδ2 expression of CD57 (A) and Tim-3 (B) on freshly isolated PBMCs among asymptomatic 
children compared between children living in high (Nagongera, n = 80) vs low (Walukuba, n = 54) transmission 
settings. Both CD57 (B) and Tim-3 (C) expression associated with reduced Vδ2+ T cell cytokine production 
following in vitro stimulation. In high transmission setting, CD57 expression on Vδ2+ T cells associated with 
increasing age (E); Tim-3 expression associated with infection status at the time of measurement (F). Rs: 
Spearman correlation. Between group comparisons made with Wilcoxon ranksum.
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Protection from P. falciparum infection. We found that higher frequencies of Vδ2+ T cells, as well as higher per-
centages of Vδ2+ T cells that produced IFNγ and TNF upon malaria antigen stimulation, were both associated 
with a significantly lower odds of subsequent P. falciparum infection in the subsequent year (Table 1). Children in 
the middle/highest strata for either of these parameters had a >50% reduced odds of subsequent infection com-
pared to children in the lowest strata (P < 0.01 for all, Table 1). These results remained significant after adjustment 
for both age and household mosquito exposure. Similarly, higher absolute counts of Vδ2+ T cell were associated 
with a lower odds of infection (OR 0.36 per 10-fold increase in Vδ2+ T cell absolute counts, 95% CI 0.15–0.85, 
P = 0.02). We also evaluated associations with protection from higher density P. falciparum infection (i.e. the odds 
of sub-microscopic infection, given any infection). After adjusting for age, children in the middle/highest strata 
of Vδ2+ T cell IFNγ/TNF co-production had a significantly higher odds of submicroscopic infection if infected 
than children in the lowest strata (OR 1.46, 95% CI 1.01–2.11, P = 0.04). These results are consistent with the 
hypothesis that Vδ2+ T cells contribute to protection against infection, possibly by limiting parasite replication.
Protection from symptoms once infected with P. falciparum. We next analyzed associations between Vδ2+ T cell 
parameters and the prospective odds of having symptoms given microscopic infection. Higher percentages of 
Vδ2+ T cells producing inflammatory cytokines IFNγ and TNF following in vitro stimulation was associated with 
an increased odds of having symptoms given P. falciparum infection. Children in the middle and highest strata of 
Vδ2+ T cell cytokine production had a >3 times higher odds of symptoms given patent blood smear infection in 
the subsequent year compared to children in the lowest strata (P = 0.004, Table 2). These results remained signif-
icant after adjusting for age (Table 2). Consistent with these findings, children who only experienced asympto-
matic infection in the subsequent year had significantly lower percentages of IFNγ/TNF-producing Vδ2+ T cells 
than children whose infections were all symptomatic (P = 0.006, Fig. 5). The frequencies and absolute counts 
of Vδ2+ T cell were not associated with the risk of symptoms once infected. Together, these results suggest that, 
among children living in a high transmission setting, the frequency and function of Vδ2+ T cells are associated 
with protection from subsequent infection, independent of age and mosquito exposure. However, once micro-
scopic infection is established, pro-inflammatory cytokine production from these cells are associated with a 
greater likelihood of symptoms.
Discussion
In this study, we extend our prior work showing that repeated malaria in children is associated with relative loss 
and in vitro dysfunction of Vδ2+ T cells,9, 23 and identify a potentially important role for Vδ2+ T cells in clinical 
immunity to malaria. We observed that, in a high transmission setting, increasing age – a proxy for cumulative 
malaria exposure – was associated with diminished in vivo Vδ2+ T cell expansion following malaria and loss of 
absolute numbers of Vδ2+ T cells, consistent with the hypothesis that repeated malaria is associated with both in 
vitro and in vivo dysfunction of these cells. Microscopic parasitemia and Vδ2 expression of Tim-3 and CD57 – 
two immunoregulatory markers found to be increased among children highly exposed to malaria - were asso-
ciated with diminished Vδ2+ T cell pro-inflammatory cytokine production. Finally, by leveraging longitudinal 
follow-up among a large cohort of children of varying ages, we observed that higher Vδ2+ T cell counts and 
cytokine production were associated with protection from subsequent Pf infection among children living in a 
Predictora N (%)
Prevalence of any 
infection (n/N, %)
Unadjustedb Adjustedc
OR 95% CI p-value aOR 95% CI p-value
Percentage Vδ2+ among CD3+
Low (0.06–0.38) 93 (35.1) 300/346, 88% Ref Ref Ref Ref Ref Ref
Middle (0.38–0.87) 92 (34.7) 258/340, 76% 0.44 0.26–0.75 0.002 0.49 0.30–0.82 0.007
High (0.88–8.7) 80 (30.2) 215/303, 71% 0.34 0.20–0.59 <0.001 0.35 0.21–0.59 <0.001
Percentage IFNγ+/TNFα+ Vδ2+
Low (0.84–27.8) 95 (35.9) 298/350, 85% Ref Ref Ref Ref Ref Ref
Middle (28.2–40.3) 91 (34.3) 254/339, 75% 0.44 0.26–0.76 0.003 0.49 0.29–0.83 0.008
High (40.6–67.0) 79 (29.8) 221/300, 74% 0.41 0.24–0.72 0.002 0.47 0.27–0.81 0.007
Age Category
0 - < 4 80 (30.2) 217/309, 70% Ref Ref Ref Ref Ref Ref
≥4 - < 7 87 (32.8) 272/336, 81% 2.00 1.19–3.38 0.009 1.64 0.99–2.73 0.055
≥7 - < 11 98 (37.0) 284/344, 83% 2.08 1.23–3.51 0.006 1.79 1.08–2.98 0.025
Mosquito Exposure Rate
1 - < 8 18 (6.8) 43/66, 65% Ref Ref Ref Ref Ref Ref
≥8 - < 40 193 (72.8) 564/724, 78% 2.12 0.86–5.24 0.102 2.40 1.04–5.56 0.04
≥40–80 40 (15.1) 122/150, 81% 2.67 0.93–7.64 0.067 3.58 1.34–9.53 0.011
≥80 14 (5.3) 44/49, 90% 6.22 1.26–30.63 0.025 8.60 1.96–37.64 0.004
Table 1. Vδ2 frequency, functional strata and protection from P. falciparum infection in subsequent year OR: 
odds ratio; aOR: adjusted odds ratio aIncludes n = 265. bFor analysis, all routine visits were considered. Odds 
of any infection at routine visits includes both submicroscopic and microscopic infections. cAdjusted for age 
category and mosquito exposure rate.
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high transmission setting. However, cytokine production from these cells was also associated with an increased 
probability of symptoms once infected. Together, these results support the hypothesis that loss and dysfunction of 
Vδ2+ T cells may represent a disease tolerance mechanism that facilitates the development of clinical immunity 
to malaria among children.
Prior studies conducted among malaria-naïve individuals and adults have found frequencies of γδ T cells to 
reach as high as 30% of circulating T cells following a symptomatic malaria episode24. We found that Vδ2+ T cells 
expand following symptomatic malaria among children living in an endemic setting, but that this expansion 
occurs primarily among young children who have had less prior malaria exposure and is significantly diminished 
among older children. As older children living in high transmission settings have experienced significantly more 
cumulative episodes of malaria during their lifetime then younger children, we speculate that the diminished 
expansion observed may be a result of repeated malaria infection. This is further supported by our observation 
that repeated malaria results in both decreased in vitro proliferation and cytokine production of Vδ2+ cells in 
response to malaria antigen stimulation9, 23. Furthermore, we have shown that repeated malaria exposure is asso-
ciated with increased expression of immunoregulatory markers, including Tim-39, whose expression is associated 
with diminished in vitro function of these cells, consistent with observations from other groups32.
We further observed an age-associated decrease in Vδ2+ T cell absolute counts among children living in 
a high transmission setting, but not in a low transmission setting. Two other reports in non-malaria endemic 
settings evaluated Vδ2+ T cells from birth through adulthood, and both reported an expansion of this subset 
with increasing age26, 27. Both of these studies also described increased expression of CD45RO among this cellu-
lar subset, a marker suggesting antigen experience. Given that Vδ2+ T cells respond to small molecular weight 
Predictor N(%)
Symptoms if infected 
(n/N, %)
Unadjusted Adjustedc
OR 95% CI p-value aOR 95% CI p-value
Percentage IFNγ+/TNFα+ Vδ2+c
Low (0.84–27.8) 95 (35.9) 73/189, 38% Ref Ref Ref Ref Ref Ref
Middle (28.2–40.3) 91 (34.3) 91/148, 61% 3.69 1.77–7.69 <0.001 2.73 1.39–5.36 0.003
High (40.6–67.0) 79 (29.8) 69/122, 57% 3.08 1.42–6.67 0.004 2.27 1.11–4.64 0.025
Age Category
0 - < 4 80 (30.2) 97/138, 70% Ref Ref Ref Ref Ref Ref
≥4 - < 7 87 (32.8) 85/176, 48% 0.30 0.15–0.60 0.001 0.35 0.18–0.70 0.003
≥7 - < 11 98 (37.0) 51/145, 35% 0.14 0.07–0.30 <0.001 0.17 0.16–0.47 <0.001
Table 2. Vδ2 functional strata and odds of symptoms if P. falciparum infected by microscopy in subsequent 
year OR: odds ratio; aOR: adjusted odds ratio. aIncludes n = 225. bFor analysis, only routine quarterly visits with 
microscopic infection were considered. Symptomatic malaria considered if blood smear positive and fever at 
visit, or within 21 days prior and 7 days following visit. cAdjusted for age category.
Figure 5. Children with fewer pro-inflammatory cytokine-producing Vδ2+ T cells are more likely to have 
asymptomatic infection. Percentage of Vδ2+ T cells producing cytokines following P. falciparum stimulation in 
children with only symptomatic vs. only asymptomatic infection in year following assay.
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phosphoantigens generated by many bacterial, mycobacterial, and parasitic organisms33–35, one may speculate 
that occasional exposure to low-density infections early in life may drive proliferation and positive selection of 
these cells. However, our observations suggest that in areas where malaria is endemic, continuous activation may 
lead to loss of Vδ2+ T cells in the peripheral circulation.
In the present study, we found that higher Vδ2+ T cell absolute counts, frequencies, and cytokine produc-
tion were associated with protection against subsequent Pf infection, and that these results remained significant 
after adjusting for heterogenous exposure to malaria-infected mosquitoes. Furthermore, higher frequencies of 
malaria-responsive Vδ2+ T cells producing inflammatory cytokines were associated with a greater likelihood 
that subsequent infections would be below the level of detection by microscopy. Together, these results suggest 
that Vδ2+ T cells may indeed play a role in limiting parasite replication in vivo19. These results are consistent with 
studies from school-aged children in Papua New Guinea which found that γδ production of IFNγ and/or TNF20, 36  
were associated with protection from clinical malaria, and a recent study from individuals receiving an experi-
mental attenuated sporozoite vaccine which found that higher frequencies of Vδ2+ T cells correlated with pro-
tection from subsequent Pf challenge21. In our prior studies, we did not observe significant associations between 
Vδ2+ T cell parameters and protection from Pf infection9, though these studies were performed in younger chil-
dren (<5 yrs of age) and did not assess for submicroscopic infection.
Though Vδ2+ T cells may possess effector functions that that can limit parasite replication, we found that 
higher frequencies of cytokine-producing Vδ2+ T cells were associated with a higher probability of symptoms 
given infection. This observation is consistent with published data suggesting that cytokine production from these 
and other cells may be responsible, in part, for mediating clinical symptoms9, 22. Taken together, our observations 
are consistent with the hypothesis that repeated malaria may drive a disease tolerance pathway among Vδ2+ T 
cells that attempts to reduce the negative impact of infection on host fitness37. Mechanisms of malaria-induced 
Vδ2+ T cell dysfunction remain to be elucidated, but may include signaling through Tim-332 and/or other immu-
noregulatory pathways, and/or changes to the epigenetic landscape of these cells38, similar to what has been 
described in several innate cellular populations in response to infection39, 40.
Given the intrinsic reactivity of Vδ2 T cells to P. falciparum and their direct anti-merozoite effects in vitro, we 
speculate that these cells may play a beneficial role as ready-made effectors during primary acute malaria infec-
tion of infants and young children, before the development of an effective adaptive immune response41. Although 
the progressive loss and dysfunction of these cells with repeated exposure is associated with reduced symptoms, 
it may conceivably interfere with effective clearance of the infection in childhood, contributing to rising parasite 
prevalence with increasing age in high transmission settings5, 8, 42. Although individuals rarely if ever develop ster-
ilizing immunity that prevents any infection, control of blood-stage parasite density improves with increasing age, 
which we speculate may be due to the eventual development of adaptive immune responses, including antibodies, 
that develop with repeated exposure. Furthermore, it is possible that as Vδ2 T cells downregulate production of 
pro-inflammatory cytokines, they acquire additional effector functions, perhaps mediated by CD16 (FcgRIII), 
which is upregulated following repeated exposure to malaria9, 23. In other contexts, CD16+ Vδ2 T cells have been 
reported to mediate phagocytosis43; hence it is possible that in older children with chronic malaria exposure, 
Vδ2 T cells may work in concert with antimalarial antibodies to restrict parasite burden.
There were several limitations to this study. Although we observed age-related differences in Vδ2+ T cells that 
parallel the development of clinical immunity to malaria, we cannot determine whether these changes are caus-
ally responsible for clinical immunity. Many immune effector populations are regulated in concert, any of which 
may contribute to this process. Furthermore, the age-associated loss and dysfunction of Vδ2+ T cells observed in 
peripheral blood in heavily malaria-exposed children could potentially reflect redistribution to the spleen, liver, 
or other tissue sites in response to malaria infections. Finally, given the cross-sectional nature of the phenotypic 
and functional assessments described, associations with protection from infection and symptoms given infection 
should be interpreted cautiously, and require validation in other cohorts and exploration in model systems.
In conclusion, our data support a growing body of studies which suggest that Vδ2+ T cells may play an impor-
tant role in protection from Pf infection20, 21, 36. However, clinical immunity to malaria may be mediated by dis-
ease tolerance mechanisms that down-modulate pro-inflammatory responses from Vδ2+ and/or other cellular 
subsets9–11, 37 and may interfere with the ability of hosts to clear and/or prevent re-infection. Although clinical 
immunity may protect children from malaria-associated morbidity and mortality, asymptomatic infection is an 
important driver of Pf transmission6, 7. Understanding the mechanisms and determinants of clinical immunity 
thus remains critically important for the success of malaria elimination strategies and for the development of 
novel vaccination strategies.
Methods
Ethical approval. Written informed consent was obtained from the parent or guardian of all study par-
ticipants. The study protocols were approved by the Uganda National Council of Science and Technology (HS 
1019), the Makerere University School of Medicine Research and Ethics Committee (Rec No. 2011–167), and the 
University of California, San Francisco Committee on Human Research (11–05995). All research was performed 
in accordance with the Declaration of Helsinki and Good Clinical Practice.
Study participants and clinical procedures. Samples were obtained from children enrolled in the East 
African International Centers of Excellence in Malaria Research cohorts. These participants live in 100 randomly 
selected households from each of two study sites with different transmission intensities: 1) Nagongera sub-county 
in Tororo district, a setting with holoendemic malaria transmission and an estimated annual entomological inoc-
ulation rate (aEIR) of 310 bites per person year, and 2) Walukuba sub-county in Jinja district, a lower transmission 
setting with an aEIR of 2.8 infectious bites per year44. In all households, all eligible children aged 6 months to 10 
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years were enrolled into the study beginning in August of 2011. The cohorts are dynamic, with children exiting 
the study at age 11, and new children born into study households enrolled at 6 months of age.
Upon enrollment all study participants were given an insecticide treated bed net and followed for all medical 
care at a dedicated study clinic. All participants were reimbursed for travel to and from clinic, and participants 
agreed to avoid all antimalarial medications administered outside the study. Children who presented with a fever 
(tympanic temperature >38.0 °C) or history of fever in the previous 24 hours had blood obtained by finger prick 
for a thick smear. If the thick smear was positive for Plasmodium parasites, the patient was diagnosed with malaria 
regardless of parasite density, and treated with artemether-lumefantrine. Routine assessments were performed in 
the study clinic every three months, including blood smears and dry blood spots to detect for parasite infection. 
Negative blood smears obtained at routine assessments were tested for the presence of submicroscopic malaria 
parasites using loop-mediated isothermal amplification (LAMP)45.
Entomologic surveys. Entomological surveys were conducted monthly beginning in October 201144. 
Each month, miniature Centers for Disease Control and Prevention light traps (Model 512; John W. Hock 
Company, Gainesville, FL) were positioned with the light 1 meter above the floor at the foot end of the bed where 
a cohort study participant slept. Traps were set at 7.00 PM and collected at 07.00 AM the following morning 
by field workers. A mosquito exposure rate was calculated for each individual based on the number of female 
Anopheles mosquitoes captured during the 12 months following the blood draw/number of house nights of col-
lection44. Mosquito exposure rate was used in analysis as a categorical variable (1- < 8, 8- < 40, 40- < 80 and ≥80 
mosquitos/household/day).
Acute and convalescent malaria absolute count measurements. Repeated assessments of T cell 
absolute counts were performed at the time of symptomatic malaria and 3,6, and 9 weeks following the malaria 
episode, in a subset of children in the Nagongera cohort (n = 43). Children were enrolled in this “sympto-
matic malaria cohort” if they met the following criteria: 1) duration of fever <48hrs; 2) P. falciparum infection 
with a parasite density >5,000/uL; 3) absence of complicated malaria; 4) no clinical suspicion of concurrent 
non-malarial illness; 5) no malaria in the prior month. Convenience sampling was used to select study partici-
pants to ensure that similar numbers of children in each of 3 age groups (0.5 - < 4 yrs, 4 - < 7 yrs, and 7- < 11 yrs) 
were included. At the time of each blood draw, 3 to 5 mls of blood were obtained in acid citrate dextrose tubes. 
25 μl of fresh whole blood was stained with CD3 PerCP, CD4 FITC, Vδ2 PE, and Vγ9 APC (all Biolegend) for 
20 minutes in a Trucount Tubes (Becton Dickinson) and then lysed and permeabilized with BD FACS Lyse buffer 
prior to acquisition on an Accuri C6 Cytometer (BD Biosciences).
Assessments in asymptomatic children at the time of routine assessments. Vδ2 phenotypic, 
absolute count, and functional assessments were obtained using convenience sampling at the time of routine 
assessments in age-matched children enrolled in both the high (Nagongera, n = 283) and lower transmission 
(Walukuba, n = 94) cohorts. Not all assessments were performed in all individuals due to sample availability. 
Measurements of cell surface phenotype and absolute counts were made utilizing fresh samples obtained at rou-
tine visits occurring between February of 2014 and July of 2015. Measurements of cytokine production following 
in vitro stimulation were made using cryopreserved specimens collected between February and August of 2013 
at a scheduled “immunology visit.” For this “immunology visit”, children were bled if they were currently afebrile 
and did not have a recorded episode of malaria in the last 7 days. For this “immunology” visit, negative blood 
smears were tested for the presence of submicroscopic malaria parasites using PCR.
Cell surface phenotype. At the time of routine visit, 3 to 5 mls of blood were obtained in acid citrate dex-
trose tubes. Absolute count measurements were performed on 25 μl of fresh whole blood as above. Peripheral 
blood mononuclear cells (PBMC) were then isolated by density gradient centrifugation (Ficoll-Histopaque; 
GE Life Sciences) and counted. 1 × 10^6 freshly isolated PBMC were stained for 30 minutes with the following 
cell-surface antibodies: from BD Pharmingen, anti-CD8-APC-H7 (SK1); from Biolegend, anti-CD3-Pacific Blue 
(SK7), anti-Vδ2—PerCP (B6), anti-Vγ9 APC (B3), and anti-CD57 FITC (HCD57) and from R&D, anti-Tim-3-PE 
(344823), fixed with 1% paraformaldehyde, and acquired on a FACS Canto flow cytometer (BD Biosciences) with 
FACSDiva software.
Vδ2 in vitro cytokine production. At the time of the “immunology visit,” 6 to10 mls of blood were obtained 
in acid citrate dextrose tubes. Peripheral blood mononuclear cells (PBMC) were isolated by density gradient 
centrifugation (Ficoll-Histopaque; GE Life Sciences), counted, and cryopreserved in liquid nitrogen prior to 
use. Analysis of Vδ2 T cell responses to P. falciparum infected red blood cell (RBC) stimulation via intracel-
lular cytokine staining was performed as previously described9. Briefly, thawed PBMCs were rested overnight 
in 10% fetal bovine serum (Gibco) and counted before stimulation with P. falciparum infected RBCs or unin-
fected RBCs. A total of 106 PBMCs were stimulated with intact purified trophozoite/schizont-stage P. falciparum 
(clone 3D7)–infected RBCs or uninfected RBCs at an effector to target ratio of 1:2. Parasite cultures were rou-
tinely confirmed to be mycoplasma negative. Following 6 hours of stimulation, Brefeldin A and monensin (BD 
Pharmingen) were added (10 μg/mL). At 24 hours, cells were washed, and surface and intracellular staining was 
performed with the following antibodies: from BD Pharmingen, anti-CD3-PerCP (SK7), anti-CD8-APC-H7 
(SK1), anti-IFNγ- PE-Cy7 (B27), and anti-TNFα- FITC (6401.1111); from Biolegend, anti-CD4-BV650 (OKT4), 
anti-CD14-Alexa700 (M5E2), anti-CD19-Alexa700 (HIB19); from Miltenyi anti- Vδ2—APC (123R3); and from 
Invitrogen, Live/Dead aqua amine. Additional experiments utilized anti-Tim-3 PE (R&D Biosciences, clone 
344823) and anti-CD57 BV 421 (Biolegend, Clone HCD57). Samples were acquired on a BD LSR2 flow cytometer 
with FACSDiva software.
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Flow cytometric data analysis. Flow cytometry data were analyzed using FlowJo software (Tree Star, San 
Carlos, California). Color compensation was performed using single-color cell controls or beads stained for each 
fluorochrome. Absolute cell counts were calculated using the manufacturer recommendations (BD Biosciences). 
For surface phenotype and functional assays, cells were gated as lymphocytes/singlets/CD14−CD19−Aqua−/
CD3+/Vδ2+. For cell surface phenotypes, gates were set using fluourescence-minus one controls. Cytokine 
production was gated as the percentage of Vδ2+ T cells producing IFNγ and TNFα. To calculate frequencies 
of P. falciparum–specific T cells, background responses to uninfected RBCs were subtracted from each subset. 
Thresholds for cell surface phenotype were set based on fluorescence-minus-one controls.
Statistical data analysis. All statistical analyses were performed using Prism 6.0 (GraphPad) and/or 
STATA version 14 (College Station).
Acute and convalescent malaria. Comparisons of absolute counts between timepoints were made using the 
Wilcoxon matched pairs signed-rank test. Associations between age strata and Vδ2 T cell absolute counts at 0, 3, 
6, and 9 weeks following acute malaria were measured using generalized estimating equations regression analysis 
with robust standard errors to account for repeated measures in the same child, after adjustment for day 0 parasite 
density. These models were assessed for significant interaction between age strata and weeks following the acute 
malaria episode.
Asymptomatic children. Comparisons of immune parameters between groups were made using the Wilcoxon 
rank sum test. Continuous variables were compared using Spearman correlation. Associations between Vδ2 T cell 
responses and the subsequent odds of infection or symptoms when infected were assessed in the year following 
the assessment. For these analyses, only the infection status at the time of routine quarterly surveillance was 
considered. At each routine assessment, children were divided into one of four mutually exclusive categories: 1) 
Symptomatic malaria, with a window of 21 days prior to and 7 days following the routine visit to ensure capture 
of malaria episodes that were recently treated or infections that soon became symptomatic; 2) Asymptomatic, 
microscopic (blood smear+) infection; 3) Asymptomatic, submicroscopic (LAMP+) infection; or 4) No evi-
dence of parasite infection. Associations between Vδ2 T cell responses and the prospective odds of any infection 
(including submicroscopic and microscopic infections), sub-microscopic infection (given infection), or symp-
toms when infected (detected by microscopy) were calculated using multilevel mixed-effects logistic regression. 
This analysis accounted for repeated measures within individuals and was clustered on household to account 
for multiple children living in the same household. In multivariate analysis, odds ratios for infection risk were 
adjusted for age (categorical) and mosquito exposure (categorical); odds ratios for symptoms when infected were 
adjusted for age. In all models, non-normal variables were log-transformed where appropriate. In all analyses, a 
2-tailed P value < 0.05 was considered to be statistically significant.
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